Fig 1. Summary of key recommendations. ALN, axillary lymph node; ALND, axillary lymph node dissection; CDK, cyclin-dependent kinase; cm, centimeter; H, high; HER2 ...

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental effect on outcomes in most cases, continuing a trend toward less ...

Characterization of breast tumors and the tumor immune landscape in young, diverse participants of the Northern California Breast Cancer Family Registry. Single arm prospective study evaluating the ...

The role of postmastectomy chest-wall irradiation in patients with breast cancer classified as pN1 (with involvement of one to three axillary nodes) or pN0 (pathologically node negative) with ...

Omitting completion axillary lymph node dissection does not increase risk for death for patients with clinically node-negative breast cancer, but it does significantly improve arm distress.Data from ...

In almost all solid tumors—i.e. cancers with a solid tissue structure—the detection of tumor cells in the lymph nodes is considered a decisive marker for the progression of the disease. Lymph node ...

Under new legislation, women in Colorado are seeing changes around breast health services. Colorado is one of several states with laws stating that health plans must cover comprehensive breast imaging ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. BeSound’s dashboard shows screening results, BI-RADS findings, and personalized breast ...

Your breast cancer pathology report is one of the most important documents you’ll get during the diagnostic process. It can be packed with information and may include many strange-sounding terms. If ...